Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02198443
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:17.422677+00:00
Published At
2017-02-23T00:00:00+00:00
Record Updated At
2017-02-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["HIV"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-02-23"
protocolSection.identificationModule.nctId
"NCT02198443"
protocolSection.identificationModule.officialTitle
"Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada \u00ae) + Lopinavir/Ritonavir (Kaletra \u00ae) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild \u00ae). Prospective, Randomized, Open."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • HIV (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.